Gavriilaki E, Sakellari I, Labopin M, Bornhauser M, et al. Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Ac Bone Marrow Transplant 2023 Jul 7. doi: 10.1038/s41409-023-02028.
PMID: 37420011